Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J L H

Showing results (201-210 of 441) with videos related to

Pageof 45
Sort By:
BJU International|March 18, 2011
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcomeAgnes Marije Hoogland, Anna Dahlman, Kees J Vissers, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
The Journal of Urology|December 13, 2006
Questionnaires to assess urinary and anal incontinence: review and recommendationsK N L Avery, J L H R Bosch, M Gotoh, et al.
Journal of Pediatric Urology|October 2, 2018
Comparison of preputioplasty and circumcision in distal hypospadias correction: long-term follow-upI A L van den Dungen, S P Rynja, J L H R Bosch, et al.
Journal of Personalized Medicine|December 16, 2020
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted BiopsiesDaniël F Osses, Christian Arsov, Lars Schimmöller, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 31, 2017
A systematic review on cell-seeded tissue engineering of penile corporaDorien E C M de Vocht, Vincent de Kemp, J D Iljas, et al.
European Urology|July 20, 2010
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic testMonique J Roobol, Fritz H Schröder, Pim van Leeuwen, et al.
Cancers|September 28, 2023
Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic ReviewFarbod Khoraminia, Saul Fuster, Neel Kanwal, et al.
Journal of Pediatric Urology|September 16, 2019
Coping styles in patients with hypospadiasSybren P Rynja, J L H Ruud Bosch, Tom P V M de Jong, et al.
European Urology|January 30, 2007
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screeningRenske Postma, Fritz H Schröder, Geert J L H van Leenders, et al.
Pageof 45

Showing results (201-210 of 441) with videos related to

Sort By:
Pageof 45
BJU International|March 18, 2011
Cysteine-rich secretory protein 3 and β-microseminoprotein on prostate cancer needle biopsies do not have predictive value for subsequent prostatectomy outcomeAgnes Marije Hoogland, Anna Dahlman, Kees J Vissers, et al.
BJU International|June 13, 2009
Body mass index is not a prognostic marker for prostate-specific antigen failure and survival in Dutch men treated with brachytherapyJoep G H van Roermund, Karel A Hinnen, Jan J Battermann, et al.
The Journal of Urology|December 13, 2006
Questionnaires to assess urinary and anal incontinence: review and recommendationsK N L Avery, J L H R Bosch, M Gotoh, et al.
Journal of Pediatric Urology|October 2, 2018
Comparison of preputioplasty and circumcision in distal hypospadias correction: long-term follow-upI A L van den Dungen, S P Rynja, J L H R Bosch, et al.
Journal of Personalized Medicine|December 16, 2020
Equivocal PI-RADS Three Lesions on Prostate Magnetic Resonance Imaging: Risk Stratification Strategies to Avoid MRI-Targeted BiopsiesDaniël F Osses, Christian Arsov, Lars Schimmöller, et al.
Journal of Tissue Engineering and Regenerative Medicine|May 31, 2017
A systematic review on cell-seeded tissue engineering of penile corporaDorien E C M de Vocht, Vincent de Kemp, J D Iljas, et al.
European Urology|July 20, 2010
Performance of the prostate cancer antigen 3 (PCA3) gene and prostate-specific antigen in prescreened men: exploring the value of PCA3 for a first-line diagnostic testMonique J Roobol, Fritz H Schröder, Pim van Leeuwen, et al.
Cancers|September 28, 2023
Artificial Intelligence in Digital Pathology for Bladder Cancer: Hype or Hope? A Systematic ReviewFarbod Khoraminia, Saul Fuster, Neel Kanwal, et al.
Journal of Pediatric Urology|September 16, 2019
Coping styles in patients with hypospadiasSybren P Rynja, J L H Ruud Bosch, Tom P V M de Jong, et al.
European Urology|January 30, 2007
Cancer detection and cancer characteristics in the European Randomized Study of Screening for Prostate Cancer (ERSPC)--Section Rotterdam. A comparison of two rounds of screeningRenske Postma, Fritz H Schröder, Geert J L H van Leenders, et al.
Pageof 45